Digitisation | November 14, 2023
Bayer and Recursion focus research collaboration on Oncology
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
The medical device sector is considered as one of the sunrise sectors in the country
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Urges Innovators to produce quality products that can be deployed at scale
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
